Is Azacitidine Injection (Vidaza) in shortage?
Yes. Azacitidine Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why it’s in shortage
- Demand increase for the drug
- Discontinuation of the manufacture of the drug
- Other
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)
Discontinuation of the manufacture of the drug
Maker contact: 1-888-386-1300
- Azacitidine, Injection, 100 mg (NDC 16729-306-10)
Maker contact: 866-941-7875, option 2
- Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)
On backorder. Recovery: TBD. Check wholesalers for inventory
Maker contact: 888-238-7880
- Vidaza, Injection, 100 mg (NDC 59572-102-01)
Maker contact: 1-888-423-5436
- Azacitidine, Injection, 100 mg (NDC 68001-313-56)
Estimated recovery: TBD
Maker contact: 800-545-8800
- Azacitidine, Injection, 100 mg (NDC 43598-305-62)
Available to existing customers
Maker contact: 866-732-3952
- Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01)
Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Maker contact: 1-800-631-2174
- Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30)
Maker contact: 844-824-8426
- Azacitidine, Injection, 100 mg (NDC 72485-201-01)
Estimated recovery: TBD
Maker contact: 732-637-1971
FDA recalls of Azacitidine
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Azacitidine Injection:
- Teva Pharmaceuticals USA Inc recalls Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint
- Dr. Reddy's Laboratories, Inc. recalls Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530
- Dr. Reddy's Laboratories, Inc. recalls Azacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530
- Shilpa Medicare Limited recalls Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial,
Azacitidine Injection shortage questions
Is Azacitidine Injection (Vidaza) in shortage?
Yes. Azacitidine Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why is there a Azacitidine Injection shortage?
FDA records the reason as: Demand increase for the drug; Discontinuation of the manufacture of the drug; Other.
What should I do if I can’t get Azacitidine Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.